Streetwise Company Fact Sheet2025/8/4 0:46:37
(SVA:TSX.V - SEOVF:OTCQB - PSH:XETRA)
Analyst coverage
| Rodman & Renshaw — Dr. Tony Butler |
| Raymond James — Michael Freeman |
| Leede Financial Inc. — Dr. Douglas Loe |
| Leede Jones Gable — Doug Loe |
| H.C. Wainwright & Co. — Dr. Joseph Pantginis |
| Echelon Capital Markets — Stefan Quenneville |
| Raymond James — Rahul Sarugaser |
| Research Capital Corporation — Dr. Andre Uddin |
Newsletter coverage
| — |
| — |
Company News
| View Latest News |
Streetwise Reports Articles
| 07/15/2025 - View Article |
| 07/14/2025 - View Article |
| 07/10/2025 - View Article |
| 06/26/2025 - View Article |
| 06/23/2025 - View Article |
Streetwise - Sernova Biotherapeutics Inc. Ownership Overview*
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA)
Company News
7/9/2025 – Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
5/22/2025 – Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes
5/14/2025 – Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
